Table 2.
Demographic characteristics of people with an HCV notification, by type of liver disease and time period.
| all HCVa | Period of DC and HCC diagnosis |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2002–2007 |
2008–2014 |
2015–2022 |
||||||||
| all HCV | DC | HCC | all HCV | DC | HCC | all HCV | DC | HCC | ||
| Characteristics, n (%) | n = 112,277 | n = 24,277 | n = 1131 | n = 288 | n = 21,112 | n = 2047 | n = 888 | n = 21,784 | n = 2341 | n = 1448 |
| Person-years at riskb | 1,748,365 | 341,639 | 859,731 | 1,549,430 | ||||||
| Year of birth, median (IQR)c,d | 1967 (1959–1977) | 1967 (1959–1976) | 1956 (1949–1960) | 1949 (1936–1956) | 1971 (1961–1981) | 1958 (1953–1963) | 1955 (1948–1958) | 1977 (1965–1988) | 1961 (1956–1967) | 1958 (1953–1962) |
| Age at diagnosis, median (IQR)c,d,e | 55 (49–62) | 55 (48–62) | 49 (44–56) | 55 (49–69) | 56 (50–61) | 53 (48–58) | 57 (53–64) | 58 (52–63) | 57 (51–62) | 60 (56–65) |
| Male sexd | 72,047 (64) | 14,983 (62) | 824 (73) | 228 (79) | 13,557 (64) | 1501 (73) | 700 (79) | 15,139 (69) | 1708 (73) | 1187 (82) |
| Female sexd | 39,735 (35) | 9218 (38) | 305 (27) | 60 (20) | 7479 (35) | 539 (26) | 184 (21) | 6570 (30) | 625 (27) | 258 (17) |
| HBV coinfection | 4346 (4) | 939 (4) | 74 (7) | 21 (7) | 753 (4) | 105 (5) | 52 (6) | 502 (2) | 152 (7) | 81 (6) |
| AUD | 24,100 (22) | 5547 (23) | 646 (57) | 66 (23) | 5265 (25) | 1264 (62) | 375 (42) | 4712 (22) | 1497 (64) | 716 (49) |
| Death | 16,714 (14) | 659 (3) | 578 (51) | 188 (66) | 886 (4) | 1193 (58) | 577 (65) | 1251 (6) | 1502 (64) | 926 (64) |
| Age at death, median (IQR)c,d | 55 (46–64) | 54 (45–63) | 53 (47–61) | 58 (51–73) | 55 (45–63) | 56 (51–61) | 59 (54–66) | 56 (44–64) | 59 (53–64) | 61 (57–66) |
| Charlson comorbidity index 3+f | 10,013 (9) | 2408 (10) | 331 (29) | 94 (33) | 1805 (9) | 626 (31) | 318 (36) | 1176 | 787 (34) | 529 (37) |
Demographic characteristics of people with an HCV notification, by type of liver disease and time period.
DC, decompensated cirrhosis; HCC, hepatocellular carcinoma; HBV, Hepatitis B virus, AUD, Alcohol use disorder.
a
Data from people in New South Wales, 1995–2022 (n = 112,277).
b
Cumulative time contributed by individuals with HCV notifications until death or diagnosis of DC/HCC.
c
Interquartile range.
d
Among people with available information.
e
Diagnosis of decompensated cirrhosis (DC) or hepatocellular carcinoma (HCC).
f
Charlson comorbidity index score is an indicator of health; higher scores indicate worse health condition.